These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 5015934)

  • 1. The anticoagulant activity of 3-1-phenyl-propyl-4-hydroxycoumarin in patients on "long-term" therapy.
    Bourgain RH; Vanden Driessche R; Smets P
    Arch Int Pharmacodyn Ther; 1972 Feb; 195(2):240-6. PubMed ID: 5015934
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anticoagulant of indirect action nitropharin].
    Lakin KM; Smirnova TV; Karaseva MG
    Farmakol Toksikol; 1968; 31(2):184-7. PubMed ID: 5674673
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of nitro-- derivatives of warfarin on blood coagulation].
    Lakin KM; Smirnova TV; Karaseva MG; Fel'dbaum VA
    Farmakol Toksikol; 1967; 30(4):456-60. PubMed ID: 5598901
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biological study of a new antivitamin K anticoagulant 3-(alpha-acetonylbenzyl) 4-hydroxycoumarin dimethylaminoethanol. (100 cases)].
    Migne J; Monteil R; Pessereau G; Pernod J; Siau J
    Therapie; 1968; 23(3):553-66. PubMed ID: 5740621
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of daphnin on blood coagulation].
    Lakin KM; Kosheleva LI
    Farmakol Toksikol; 1968; 31(1):72-4. PubMed ID: 5675354
    [No Abstract]   [Full Text] [Related]  

  • 6. A new exogen anticoagulant with high selectivity to intrinsic pathway of coagulation.
    de Araújo RM; Vaz AF; Santos ME; Zingali RB; Coelho LC; Paiva PM; Correia MT; Oliva ML; Ferreira RS
    Thromb Res; 2011 Oct; 128(4):395-7. PubMed ID: 21752431
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of activated factors II, VII, IX, and X by synthetic organic compounds directed against the active-site seryl residue.
    Van der Woerd-de Lange JA; van Dam-Mieras MC; Hemker HC
    Haemostasis; 1981; 10(6):315-47. PubMed ID: 6976920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanisms of action of oral anticoagulants].
    Uszyński L
    Acta Haematol Pol; 1972; 3(2):133-9. PubMed ID: 4655612
    [No Abstract]   [Full Text] [Related]  

  • 9. Potency and coagulation factor effects of 2,3,5,6-tetrachloro-4-pyridinol compared to warfarin and its antagonism by vitamin K.
    Marshall FN
    Proc Soc Exp Biol Med; 1972 Mar; 139(3):806-10. PubMed ID: 5023769
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of antithrombin III on the activity of the coagulation factors VII, IX and X.
    Osterud B; Miller-Andersson M; Abildgaard U; Prydz H
    Thromb Haemost; 1976 Apr; 35(2):295-304. PubMed ID: 61631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Action of neodymium 3-sulfo-isonicotinate on the mechanism of coagulation in guinea pigs and rabbits].
    Tremblay J; Archambault A
    Rev Can Biol; 1967 Mar; 26(1):1-9. PubMed ID: 6053477
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on 4-hydroxy-I-thiacoumarins: VI--anticoagulant activity and chemical structure in 4-hydroxy-I-thiacoumarins and related compounds.
    Jamkhandi PS; Rajagopal S; Sirsi M
    Indian J Exp Biol; 1968 Oct; 6(4):224-6. PubMed ID: 5720680
    [No Abstract]   [Full Text] [Related]  

  • 13. Interactions of bexarotene (LGD1069, Targretin) with the coagulation system.
    Hespel A; Mejdoubi-Charef N; Yous S; Courty J; Papy-Garcia D; Charef S
    Cancer Chemother Pharmacol; 2011 Oct; 68(4):847-54. PubMed ID: 21229355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulant activity of Heraclenin.
    Mishra KC; Sharma RC; Sharma YN; Arora RB
    Indian J Physiol Pharmacol; 1969 Jul; 13(3):153-5. PubMed ID: 5362630
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacology of oral anticoagulants].
    Richter M; Markwardt F
    Z Gesamte Inn Med; 1979 Jan; 34(1):8-17. PubMed ID: 433362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Protein synthesis induced by vitamin K deficiency].
    Hemker HC
    Nouv Rev Fr Hematol; 1970; 10(5):645-51. PubMed ID: 4250287
    [No Abstract]   [Full Text] [Related]  

  • 17. [Behavior of blood coagulation factors under the effect of a new pyrazol derivative during prolonged anticoagulant therapy].
    Wolf H
    Arzneimittelforschung; 1970 Sep; 20(9):1252-8. PubMed ID: 4098759
    [No Abstract]   [Full Text] [Related]  

  • 18. [Enhanced activity of diminished blood clotting factors in inborn blood coagulation defects].
    Mingers AM; Mietens C; Ströder J
    Thromb Diath Haemorrh; 1971 Jun; 25(2):316-31. PubMed ID: 5568051
    [No Abstract]   [Full Text] [Related]  

  • 19. The inhibitor of prothrombin conversion in plasma of patients on oral anticoagulant treatment.
    Bertina RM; Westhoek-Kuipers ME; Alderkamp GH
    Thromb Haemost; 1981 Jun; 45(3):237-41. PubMed ID: 7281102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oral anticoagulant treatment; which anticoagulant?].
    Thijssen HH; Hemker HC
    Ned Tijdschr Geneeskd; 1984 Aug; 128(33):1559-63. PubMed ID: 6483024
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.